Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
Investor Type
LinkedIn View on LinkedIn
Mark L. Perry has been an advisor to Third Rock Ventures, a venture capital firm, since 2012. He served from 2007 to 2011 as president and chief executive officer of Aerovance, Inc., a biopharmaceutical company.
He was an executive officer from 1994 to 2004 at Gilead Sciences, Inc., a biopharmaceutical company, serving in a variety of
capacities, including general counsel, chief financial officer, and executive vice president of operations, responsible for worldwide sales and marketing, legal, manufacturing and facilities; he was also its senior business advisor until 2007.
From 1981 to 1994, Mr. Perry was with the law firm Cooley LLP, where was a partner for seven years.
He serves on the boards of directors of Global Blood Therapeutics, Inc. and MyoKardia, Inc., both biopharmaceutical companies.
Mr. Perry holds a BA degree in History from the University of California, Berkeley, and a JD degree from the University of California, Davis. He joined the NVIDIA board in 2005.
